Interestingly, the researchers found no significant differences between the exenatide and placebo groups in scores of cognitive ability or depression suggesting that the positive effect of exenatide may be specific to the dopamine or motor regions of the brain
For very sensitive patients, dosing can often be given very infrequently depending on the agent selected
Ozempic and Wegovy have ushered in a rapidly expanding field of obesity drugs, with pharma firms big and small eager to cash in on the massive weight loss drug windfall Other drug candidates in mid-stage development for obesity include Viking Therapeutics VK2735, Structure Therapeutics GSBR-1290 and Altimmunes pemvidutide, Pfizers danuglipron, Amgens AMG133, also known as MariTide, and Roches CT-996 and CT-388
Wegovy (semaglutide) has received high praise from weight loss experts not only within the United States, but around the globe
The partnership with Novo Nordisk is a strong example of how GoodRx can leverage its extensive reach and scale of nearly 30 million consumers and over 1 million healthcare professionals annually to deliver meaningful savings on FDA-approved medications to people who might otherwise be priced out of therapy, Divya Iyer, senior vice president of go-to-market strategy at GoodRx told BioXconomy
